160133-33-5

Basic information

• Product Name: 2,2''-(1-BENZYLPIPERIDINE-4,4-DIYL)DIETHANOL
• Synonyms: 2,2''-(1-BENZYLPIPERIDINE-4,4-DIYL)DIETHANOL;4,4-Piperidinediethanol, 1-(phenylMethyl)-
• CAS NO: 160133-33-5
• Molecular Formula: C₁₆H₂₅NO₂
• Molecular Weight: 263.38
• Mol File: 160133-33-5.mol
• Article Data: 7

Chemical Properties

• Appearance: /
• Density: 1.077
• CAS DataBase Reference: 2,2''-(1-BENZYLPIPERIDINE-4,4-DIYL)DIETHANOL(CAS DataBase Reference)
• NIST Chemistry Reference: 2,2''-(1-BENZYLPIPERIDINE-4,4-DIYL)DIETHANOL(160133-33-5)
• EPA Substance Registry System: 2,2''-(1-BENZYLPIPERIDINE-4,4-DIYL)DIETHANOL(160133-33-5)

Safety Data

• Hazardous Substances Data: 160133-33-5(Hazardous Substances Data)

Usage

General Description

2,2''-(1-Benzylpiperidine-4,4-diyl)diethanol is a chemical compound that belongs to the category of organic compounds known as benzene and substituted derivatives. These are aromatic compounds containing one monocyclic ring system made of six carbon atoms, which is called a benzene ring despite the nature of the substituents. The presence of the benzylpiperidine structure suggests potential uses in pharmaceutical settings, notably in the synthesis of various drugs. As a complex organic compound, its properties, the safety measures surrounding its handling, and potential reactions depend on the specific context of its usage. Further detailed study is required to fully understand its characteristics and potential applications.

Upstream product

• 160133-32-4 ethyl 2-[1-benzyl-4-(2-ethoxy-2-oxoethyl)-4-piperidyl]acetate 

Downstream Products

• 518284-85-0 2-[1-benzyl-4-[2-(tert-butyldiphenylsiloxy)ethyl]piperidin-4-yl]ethanol 
• 1225436-56-5 1-(9-(3,3-difluoroazetidin-1-yl)-9-phenyl-3-azaspiro[5.5]undecan-3-yl)-2-(((S)-1-(4-methoxy-2,6-dimethylphenylsulfonyl)piperidin-2-yl)methoxy)ethanone 
• 1225436-57-6 1-[3-(3-fluorophenyl)-3-pyrrolidin-1-yl-9-azaspiro[5.5]undecan-9-yl]-2-[1-[[3-(trifluoromethyl)phenyl]sulfonyl]-piperidin-2-yl]-ethanone 
• 1225436-55-4 1-(9-(azetidin-1-yl)-9-phenyl-3-azaspiro[5.5]undecan-3-yl)-2-(((S)-1-(4-methoxy-2,6-dimethylphenylsulfonyl)piperidin-2-yl)methoxy)ethanone 
• 1225437-13-7 tert-Butyl 9-(3-fluorophenyl)-9-(pyrrolidin-1-yl)-3-azaspiro[5.5]undecane-3-carboxylate 
• 1225437-11-5 tert-Butyl 9-(3,3-difluoroazetidin-1-yl)-9-phenyl-3-azaspiro[5.5]undecane-3-carboxylate 
• 1225437-01-3 tert-Butyl 9-(azetidin-1-yl)-9-phenyl-3-azaspiro[5.5]undecane-3-carboxylate 
• 1225437-09-1 3-azaspiro[5.5]undecan-9-one hydrochloride 
• 1225437-12-6 9-(3,3-Difluoroazetidin-1-yl)-9-phenyl-3-azaspiro[5.5]undecane 
• 873924-08-4 9-oxo-3-azaspiro[5.5]undecane-3-carboxylic acid tert-butyl ester 
• 160133-34-6 1-Benzyl-4,4-bis-(2-chloroethyl)-piperidinehydrochloride 
• 170229-04-6 1-t-Butoxycarbonylpiperidine-4,4-diethanol 

Relevant articles and documents

Substituted Spiroamine Compounds

Substituted spiroamine compounds corresponding to the formula (I) In which m, n, o, p, Q, r, s, t, R1, R2, R3, R4a, R4b, R5a, R5b, R6a, R6b, R7, R8, R9, R10 and R11 have defined meanings; a process for the preparation of such compounds, pharmaceutical compositions containing such compounds and the use of substituted spiroamines for the treatment or inhibition of pain and/or other conditions mediated by the bradykinin 1 receptor.

Preparation of benzodiazepinone derivatives for treatment of cardiac arrhythmias and pharmaceutical composition containing them.

-

Cyclic urea derivatives, pharmaceutical compositions containing these compounds and processes for preparing them

The invention relates to cyclic urea derivatives of general formula I STR1 wherein Ra, Rb, X and Y are defined as in claim 1, the tautomers, stereoisomers and salts thereof, particularly the physiologically acceptable salts thereof with inorganic or organic acids or bases, which have valuable pharmacological properties, preferably aggregation inhibiting effects, and to drugs containing the compounds and processes for preparing them.